In addition, previous research revealed that several CKM components, including diabetes and obesity, may alter free fatty acids and branched-chain amino acids (BCAAs) by insulin resistance and systemic inflammation (14, 15), which were key pathological processes shared by CKM syndrome and MALOs. The gene discussed is CKM; the disease is obesity due to melanocortin 4 receptor deficiency.